Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

PURPOSE: Patients with metastasized breast cancer often suffer from discomfort caused by metastatic bone disease. Thus, osteoprotection is an important part of therapy in breast cancer metastasized to bone, and bisphosphonates (BPs) are a major therapeutic option. In this study, our objectives were...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: von Au, Alexandra, Milloth, Eva, Diel, Ingo, Stefanovic, Stefan, Hennigs, Andre, Wallwiener, Markus, Heil, Joerg, Golatta, Michael, Rom, Joachim, Sohn, Christof, Schneeweiss, Andreas, Schuetz, Florian, Domschke, Christoph
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2016
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944913/
https://ncbi.nlm.nih.gov/pubmed/27468239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S103130
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky